Re-Vana Therapeutics

Belfast, United Kingdom

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

$12.1M raised

Nov 2022

Series A

Health Care Market Research Medical Therapeutics

Top Investors

SyndicateRoom MassChallenge Techstart Ventures Visionary Venture Fund ExSight Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Re-Vana Therapeutics

How much funding has Re-Vana Therapeutics raised?

Re-Vana Therapeutics has raised $12.1M in total funding. The most recent round was Series A. The last funding was announced in November 2022.

Who are Re-Vana Therapeutics's investors?

Re-Vana Therapeutics's investors include SyndicateRoom, MassChallenge, Techstart Ventures, Visionary Venture Fund, ExSight Ventures.

Where is Re-Vana Therapeutics headquartered?

Re-Vana Therapeutics is headquartered in Belfast, United Kingdom.

What does Re-Vana Therapeutics do?

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

What stage is Re-Vana Therapeutics at?

Re-Vana Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 30, 2022.

MLA

"Re-Vana Therapeutics — Funding & Investors." VCBacked, November 30, 2022, https://www.vcbacked.co/company/re-vana-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Re-Vana Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/re-vana-therapeutics

Wikipedia (cite web)

{{cite web |title=Re-Vana Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/re-vana-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 30, 2022.